Top 10 Healthcare AI Stocks to Buy According to Hedge Funds

4. Evolent Health, Inc. (NYSE:EVH)

Number of Hedge Fund Holders: 37

Evolent Health, Inc. (NYSE:EVH) is one of the top 10 healthcare AI stocks to buy according to hedge funds. JMP Securities reaffirmed its Market Outperform rating and $13.00 price target on Evolent Health, Inc. (NYSE:EVH), highlighting a more stable and promising outlook for the company. The firm described Evolent’s current risk/reward profile as “favorably skewed,” citing a series of operational improvements and strategic shifts that have put the company on firmer footing than in recent years.

Evolent, which provides value-based care solutions to payers and providers, has made notable progress in restructuring its risk-based arrangements and enhancing contracting mechanisms. These efforts have contributed to a healthier balance of performance obligations and upside potential. JMP noted that a strong pipeline of new business and improved visibility into existing partnerships support the firm’s bullish view. While 2025 is expected to be a trough earnings year, JMP expressed increased confidence in Evolent’s profit trajectory going forward. A key factor is the anticipated moderation in oncology-related cost trends, which have historically posed volatility in the company’s earnings profile.

Evolent Health, Inc. (NYSE:EVH) operates as a healthcare AI company, using predictive analytics and machine learning to manage complex populations, optimize clinical interventions, and reduce unnecessary costs. Its platform supports providers in making data-informed decisions, particularly in specialties like oncology and cardiology. With improved structural alignment and growing technological leverage, Evolent is well-positioned to capture long-term value in the transition to outcome-driven healthcare.